Navigation Links
Cord Blood America Updates Its Stem Cell Collection Business in China
Date:10/26/2010

LAS VEGAS, Oct. 26 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced its Chairman, CEO and co-founder, Matthew Schissler, has updated progress on the Company's stem cell collection business in China in an interview with analyst Francis Gaskins.

The entire interview is available at:  http://gaskinsco.com/cbai-10-25-10.mp3.

In the interview, Mr. Schissler explains some changes to the structure of the transaction since the original announcement on March 31, 2010.  

Several parties, including Cord Blood America, have formed a new company, China Stem Cells, Ltd., to oversee the project.  Mr. Schissler will serve as President of the new company.

Cord Blood America will provide advisory and consulting expertise, proprietary technology and know-how on the processing and storage of stem cells, for which it will receive royalties and an equity stake.  The new company already is completing a laboratory in China for stem cell storage, with storage expected to begin in late 2010 or early 2011.  Plans are moving forward to build a larger laboratory in China within two years.

"This is a more cost effective, smoother process and it gives Cord Blood America a strategic footprint into the Far East," Mr. Schissler said.  He explained that the Chinese are storing stem cells at rates faster than the U.S. and Europe.

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.

CONTACT:

Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com




'/>"/>
SOURCE Cord Blood America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CryoLife Begins Distribution of Blood-Clotting Agent PerClot® in Europe
2. Fenwal Named Exclusive Provider of AccuVeins Award-Winning Vein Illumination Device for Blood and Plasma Centers
3. Tocotrienols Shown to be Effective in Lowering Fat Levels in Blood
4. Blood Pressure Pills More Effective When Taken at Night
5. First of many Neuro-Biotechs licensed products, "SymPath(R) blood test"
6. Innovations to Omron Healthcare Home Blood Pressure Monitors Provide New Solutions for Consumers
7. Three U.S. Hospitals Reduce Costly Catheter-Related Bloodstream Infections
8. Effective Self-Management of Blood Glucose Can be Achieved by Using Meters With Advanced Features Paired With Diabetes Education
9. Biomatrica Launches DNAgard® Blood and DNAstable Blood for Stabilization, Storage and Shipping of Whole Blood at Room Temperature
10. Adding Lantus® to Oral Antidiabetic Drug Therapy Further Reduced Blood Sugar in Patients with Type 2 Diabetes
11. China Cord Blood Corporation Announces Mandate for Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):